Career Development Program

职业发展计划

• 批准号: 8485830
• 负责人: SHASHIKANT LELE
• 金额: $ 10.76万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-18 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8485830
• 关键词: Advocate; Award; Clinical; Development; Disorder by Site; Faculty; Funding; Goals; Group Meetings; Individual; Malignant neoplasm of ovary; Mentors; Nursing Faculty; Patients; Population Programs; Process; Recommendation; Research; Research Personnel; Research Training; Resources; Series; Specimen; Structure; Study Section; Target Populations; Tissues; United States National Institutes of Health; University of Pittsburgh Cancer Institute; anticancer research; career; career development; experience; interest; meetings; next generation; novel; population based; professor; programs

The purpose of the Career Developmental Program (CDP) of the RPCI-UPCI Ovarian Cancer SPORE is to support the career development of junior researchers in translational ovarian cancer research. The target population for the program is outstanding entry-level (i.e. Assistant Professor) scientific and clinical faculty, but in some cases may include senior postdoctoral or clinical fellows with exceptional potential for independent research careers, or established investigators wishing to refocus their careers on translational ovarian cancer research. A secondary goal of the CDP is to promote the diversity of ovarian cancer researchers, by encouraging the recruitment of outstanding individuals from underrepresented groups. The CDP will be supported both by RPCI-UPCI Ovarian Cancer SPORE funds and matching institutional funds from RPCI and UPCI. The CDP serves as a structured mechanism for identifying outstanding candidates through an open and competitive application and review process, and matching the resulting awardees with experienced mentors. The CDP Leaders will convene a NIH format study section and assign NIH R21-type applications to two scientific and one patient advocate reviewers. Review results will be summarized in the Administrative Core and submitted to the Internal Advisory Board for recommendations for funding. Successful applications will be funded at the level of $50,000 per year for of two years (total award $100,000). We anticipate to fund three to five awards per year depending on the funding year. CDP awardees will be provided full access to the RPCI-UPCI Ovarian Cancer SPORE Core resources, including tissue specimens and statistical support. The CDP will directly facilitate career development through: i) a constructive proposal review by the RPCI-UPCI Ovarian Cancer SPORE Executive Committee and Internal Advisory Board, which are composed of talented investigators with expertise in basic, clinical, and population-based research, ii) research training with a mentor chosen from among a diverse faculty with broad expertise in academic career development, and iii) access to development/enrichment programs, including ovarian cancer disease site research group meetings, periodic SPORE meetings, seminar series, and RPCI-UPCI Ovarian Cancer SPORE annual retreats. In summary, the CDP provides a vital mechanism for the development of the next generation of translational ovarian cancer researchers at RPCI and UPCI.

RPCI-UPCI卵巢癌孢子的职业发展计划（CDP）的目的是支持转化卵巢癌研究中的初级研究人员的职业发展。该计划的目标人群是出色的入门级（即助理教授）科学和临床教师，但在某些情况下，可能包括高级博士后或临床研究员，具有极大的独立研究职业潜力，或者希望将其职业重新聚焦于翻译卵巢癌研究的研究人员。 CDP的次要目标是通过鼓励从代表性不足的群体中招募杰出的个体来促进卵巢癌研究人员的多样性。 CDP将由RPCI-UPCI卵巢癌孢子基金和RPCI和UPCI的机构基金提供支持。 CDP是一种结构化机制，可通过开放且竞争性的应用程序和审查过程来识别出色的候选人，并将最终的获奖者与经验丰富的导师相匹配。 CDP领导者将召集NIH格式研究部分，并将NIH R21型应用程序分配给两个科学和一名患者倡导者审稿人。审查结果将在行政核心中汇总，并提交给内部咨询委员会以获取资金建议。成功的申请将获得两年的每年50,000美元的资金（总奖励100,000美元）。我们预计，根据资金年度，每年将为三到五个奖项提供资金。 CDP获奖者将被完全访问RPCI-UPCI卵巢癌孢子核心资源，包括组织标本和统计支持。 CDP将通过以下方式直接促进职业发展：i）RPCICI-UPCI卵巢癌孢子执行委员会和内部顾问委员会的建设性提案审查，由在基础，临床和人群基于临床和人群的研究方面具有专业知识的才华横溢的研究人员组成定期孢子会议，研讨会系列和RPCI-UPCI卵巢癌孢子年度静修。总而言之，CDP为RPCI和UPCI的下一代卵巢癌研究人员的发展提供了至关重要的机制。